Total planned funding: $513,201,075
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $208,717,439 |
Zambia | $97,280,098 |
Mozambique | $40,119,575 |
Vietnam | $29,992,701 |
South Africa | $16,430,345 |
Tanzania | $14,363,312 |
Kenya | $14,305,661 |
Ghana | $9,732,500 |
Botswana | $9,399,720 |
Côte d'Ivoire | $8,541,571 |
Haiti | $8,118,100 |
Papua New Guinea | $6,494,909 |
Democratic Republic of the Congo | $6,491,445 |
Rwanda | $5,995,652 |
India | $5,472,700 |
Burundi | $5,189,907 |
South Sudan | $4,568,967 |
Guyana | $4,375,000 |
Uganda | $3,423,638 |
Ethiopia | $3,198,267 |
Namibia | $3,157,568 |
Indonesia | $2,480,000 |
Angola | $2,250,000 |
Eswatini | $1,940,000 |
Malawi | $712,000 |
Lesotho | $250,000 |
Dominican Republic | $200,000 |
Cambodia | $0 |
Caribbean Region | $0 |
Organizational Types
NGO | $513,201,075 |
Program Areas
Care | $143,328,135 |
Treatment | $118,561,398 |
Prevention | $114,635,429 |
Governance and Systems | $50,101,682 |
Testing | $31,728,431 |
Budget Codes
HTXS: Treatment: Adult Treatment | $101,424,429 |
HBHC: Care: Adult Care and Support | $64,110,969 |
HKID: Care: Orphans and Vulnerable Children | $54,668,430 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $54,179,886 |
HVOP: Sexual Prevention: Other Sexual Prevention | $42,982,438 |
HVCT: Testing: HIV Testing and Counseling | $31,728,431 |
HLAB: Laboratory Infrastructure | $22,442,011 |
PDTX: Treatment: Pediatric Treatment | $17,136,969 |
OHSS: Health Systems Strengthening | $15,353,724 |
HVTB: Care: TB/HIV | $14,421,925 |
HVSI: Strategic Information | $12,305,947 |
PDCS: Care: Pediatric Care and Support | $10,126,811 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,200,545 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,606,223 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $4,041,015 |
HMIN: Biomedical Prevention: Injection Safety | $483,893 |
HMBL: Biomedical Prevention: Blood Safety | $141,429 |
HTXD: Treatment: ARV Drugs | $0 |